- 中文名稱
Brolucizumab 生物類似藥, VEGF-A 單克隆抗體
- 英文名字
- Brolucizumab Biosimilar, VEGF-A Monoclonal Antibody
- 供應商
- Promab
- 產品貨號
- PMB-B00053
- 產品報價
- ￥詢價/1mg/5mg/20mg
- 產品說明書
- 點擊查看
- 購買方式
- 90%產品中國有現貨庫存。銀行轉賬、電匯、支票、現金，在線支付寶及網銀支付，或直接與我們電話聯系400-6800-868
- 產品新聞
- 背景資料
- Brolucizumab Biosimilar uses the same protein sequences as the therapeutic antibody brolucizumab.nnBrolucizumab is a monoclonal antibody indicated to treat neovascular age related macular degeneration. Brolucizumab is a vascular endothelial growth factor (VEGF) inhibitor which targets the major VEGF-A isoforms: VEGF110, VEGF121, and VEGF165. Inhibition of these VEGF-A isoforms reduce proliferation of endothelial cells, vascularization of the tissue, and permeability of the vasculature.
- 應用類型
- Flow cytometry, animal model study
- 免疫原
- Human VEGF-A
- 來源宿主
- CHO cells
- 反應性
- Human
- 保存建議
- Store at 4°C 1 month, store at -20°C to -70°C 12 month. protected from prolonged exposure to light. Avoid freeze/thaw cycles.
- 其他
- VEGF, VEGF-A, vascular endothelial growth factor A
- 注意
-
該頁面的中文產品信息的翻譯，僅供參考。準確的產品信息請以廠家的英文說明書為準。下單前，請瀏覽說明書確認。
-
